Drug Shortage Report for DEXTROSE INJECTION
Report ID | 254610 |
Drug Identification Number | 02517132 |
Brand name | DEXTROSE INJECTION |
Common or Proper name | DEXTROSE INJECTION USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 50% |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 50mL vial / fiole |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2025-04-14 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-15 |
Company comments | Some product available at CPDN. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2025-04-15 | English | Compare |
v2 | 2025-04-08 | French | Compare |
v1 | 2025-04-08 | English | Compare |
Showing 1 to 3 of 3